Sanlam Limited:企業の戦略・SWOT・財務情報

◆英語タイトル:Sanlam Limited - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C5624
◆発行会社(調査会社):MarketLine
◆発行日:2018年10月
◆ページ数:44
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:南アフリカ
◆産業分野:サービス
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Sanlam Limited – Strategy, SWOT and Corporate Finance Report
Summary

Sanlam Limited – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Sanlam Limited (Sanlam) is a provider of financial services. The company, through its subsidiaries, offers personal, business and institutional financial solutions. Its financial solutions include life insurance, general insurance, and investment management including asset management, retail savings and wealth management, credit and structuring, retirement fund administration, health and other services such as estate planning, wills, trusts, unsecured lending and health management. Sanlam also provides financial planning and electronic financial transaction services. The company offers these services to individuals, corporate customers and institutions. Its operations are spanned across South Africa, the UK, India, Australia, Malaysia and the US markets. Sanlam is headquartered in Bellville, South Africa.

The company reported gross written premium of ZAR25, 909 million during the fiscal year 2016 (FY2016), representing an increase of 6.5% over FY2015. Its net earned premium was ZAR19, 826 million in FY2016, an increase of 7% over FY2015.

Scope

- Detailed information on Sanlam Limited required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Sanlam Limited in the form of a SWOT analysis
- An in-depth view of the business model of Sanlam Limited including a breakdown and examination of key business segments
- Intelligence on Sanlam Limited’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Sanlam Limited, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Sanlam Limited and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Sanlam Limited as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Sanlam Limited’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
Sanlam Limited: Company Overview 9
Sanlam Limited: Overview and Key Facts 9
Sanlam Limited: Overview 9
Sanlam Limited: Key Facts 9
Sanlam Limited: Key Employees 10
Sanlam Limited: Key Employee Biographies 12
Sanlam Limited: Major Products and Services 13
Sanlam Limited: Company History 14
Sanlam Limited: Management Statement 17
Sanlam Limited: Locations and Subsidiaries 22
Sanlam Limited: Key Competitors 23
Sanlam Limited: Company Analysis 24
Sanlam Limited: Business Description 24
Sanlam Limited: SWOT Analysis 26
Sanlam Limited: SWOT Overview 26
Sanlam Limited: Strengths 26
Sanlam Limited: Weaknesses 27
Sanlam Limited: Opportunities 27
Sanlam Limited: Threats 28
Sanlam Limited: Corporate Financial Deals Activity 29
Sanlam Limited: Financial Deals Overview 29
Sanlam Limited: Targets and Partners 31
Sanlam Limited: Top Deals 2014 – 2018YTD* 32
Sanlam Limited: Mergers and Acquisitions 33
Sanlam Limited: Divestments 34
Sanlam Limited: Recent Developments 35
Sanlam Limited: News and Events Summary 35
Sanlam Limited: Business Expansion 38
Sanlam Limited: Contracts 38
Sanlam Limited: Corporate Governance 39
Sanlam Limited: Financial Deals 40
Sanlam Limited: Financial Performance 40
Sanlam Limited: Market Developments 41
Sanlam Limited: Strategy and Operations 41
Appendix 42
Contact Us 42
Methodology 42
About MarketLine 43

List of Tables
Table 1: Sanlam Limited: Key Facts
Table 2: Sanlam Limited: Key Employees
Table 3: Sanlam Limited: Company History
Table 4: Sanlam Limited: Locations and Subsidiaries
Table 5: Sanlam Limited: Key Competitors
Table 6: Sanlam Limited: Deal Activity by Deal Type - Volume (TTM*)
Table 7: Sanlam Limited: M&A Activity by Geography (TTM*)
Table 8: Sanlam Limited: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 9: Sanlam Limited: M&A Average Deal Size - Value (US$m)
Table 10: Sanlam Limited: Targets and Partners
Table 11: Sanlam Limited: Top Deals 2014 - 2018YTD*
Table 12: Sanlam Limited: M&A Volume and Value Trend (2014 - YTD*2018)
Table 13: Sanlam Limited: M&A Activity by Geography (2014 - YTD*2018)
Table 14: Sanlam Limited: Divestments Volume and Value Trend (2014 - YTD*2018)
Table 15: Sanlam Limited: News and Events Summary
Table 16: Sanlam Limited: Business Expansion
Table 17: Sanlam Limited: Contracts
Table 18: Sanlam Limited: Corporate Governance
Table 19: Sanlam Limited: Financial Deals
Table 20: Sanlam Limited: Financial Performance
Table 21: Sanlam Limited: Market Developments
Table 22: Sanlam Limited: Strategy and Operations

List of Figures
Figure 1: Sanlam Limited: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Sanlam Limited: M&A Activity by Geography (TTM*)
Figure 3: Sanlam Limited: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 4: Sanlam Limited: M&A Average Deal Size - Value (US$m)
Figure 5: Sanlam Limited: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 6: Sanlam Limited: M&A Activity by Geography (2014 - YTD*2018)
Figure 7: Sanlam Limited: Divestments Volume and Value Trend (2014 - YTD*2018)

★海外企業調査レポート[Sanlam Limited:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Mycenax Biotech Inc (4726):企業の財務・戦略的SWOT分析
    Summary Mycenax Biotech Inc (Mycenax) is a biopharmaceutical company that develops and manufactures pharmaceutical formulations. The company provides pipeline portfolio encompasses investigational candidates targeted at the treatment of plaque psoriasis, glioblastoma, asthma, adult crohn's Disease, …
  • Teco Energy Inc:企業の戦略的SWOT分析
    Teco Energy Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • University of California San Diego-製薬・医療分野:企業M&A・提携分析
    Summary University of California San Diego (UCSD), a subsidiary of University of California, is a public research university that offers education and research with a portfolio of undergraduate, graduate, postdoctoral and professional schools. It offers courses in various fields including arts and h …
  • Viettel Group:企業の戦略・SWOT・財務分析
    Viettel Group - Strategy, SWOT and Corporate Finance Report Summary Viettel Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Laboratorios Farmaceuticos Rovi SA (ROVI)-製薬・医療分野:企業M&A・提携分析
    Summary Laboratorios Farmaceuticos ROVI SA (ROVI) is a drug company that develops and manufactures diagnostic, prescription and over the counter medicinal products. The company's over the counter products include antiperspirant lotions, food supplements, oral gels, cold and hot bags to relieve pains …
  • Banca Monte dei Paschi di Siena S.p.A.:戦略・SWOT・企業財務分析
    Banca Monte dei Paschi di Siena S.p.A. - Strategy, SWOT and Corporate Finance Report Summary Banca Monte dei Paschi di Siena S.p.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • Mercer LLC:企業の戦略的SWOT分析
    Mercer LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • Neuca SA (NEU):製薬・医療:M&Aディール及び事業提携情報
    Summary Neuca SA (Neuca) is a provider of pharmaceutical and medical development solutions. The company offers wholesale of pharmaceuticals and medical equipment to pharmacies and hospitals. Its services comprise private brand management, logistics and distribution, telemarketing, and education and …
  • Aker ASA (AKER):企業の財務・戦略的SWOT分析
    Aker ASA (AKER) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Ultrapar Participacoes S.A.:企業の戦略・SWOT・財務分析
    Ultrapar Participacoes S.A. - Strategy, SWOT and Corporate Finance Report Summary Ultrapar Participacoes S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Quest Diagnostics Inc (DGX):製薬・医療:M&Aディール及び事業提携情報
    Summary Quest Diagnostics Inc (Quest Diagnostics) is a provider of diagnostic information services to patients and physicians through a chain of laboratories and company-owned patient service centers. It offers comprehensive range of services including clinical testing with gene-based and other esot …
  • Pakistan International Airlines Corporation
    Pakistan International Airlines Corporation - Strategy, SWOT and Corporate Finance Report Summary Pakistan International Airlines Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation …
  • SEEK Limited:企業のM&A・事業提携・投資動向
    SEEK Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's SEEK Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, …
  • Enel SpA (ENEL)-石油・ガス分野:企業M&A・提携分析
    Summary Enel S.p.A. (Enel) is an energy group that produces, distributes and trades electricity and natural gas. The group generates electricity using diverse sources of energy such as nuclear, renewables, oil and gas turbine, coal and gas combined cycle. It also focuses on digitizing electricity gr …
  • Ventana Medical Systems Inc-医療機器分野:企業M&A・提携分析
    Summary Ventana Medical Systems Inc (VMS), a subsidiary of F. Hoffmann-La Roche Ltd is a manufacturer of tissue-based diagnostic solutions for healthcare market. The company develops cancer diagnostic solutions for breast pathology, cervical diagnostics, colorectal pathology, special stains, lung pa …
  • Flour Mills of Nigeria Plc (FLOURMILL):企業の財務・戦略的SWOT分析
    Flour Mills of Nigeria Plc (FLOURMILL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • Addvalue Technologies Limited (A31):企業の財務・戦略的SWOT分析
    Addvalue Technologies Limited (A31) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Just the Berries Ltd:戦略・SWOT・企業財務分析
    Just the Berries Ltd - Strategy, SWOT and Corporate Finance Report Summary Just the Berries Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Allergy Therapeutics Plc (AGY):製薬・医療:M&Aディール及び事業提携情報
    Summary Allergy Therapeutics Plc (Allergy Therapeutics) is a specialty pharmaceutical company that develops therapies for allergy treatment and allergy prevention. The company offers a wide range of aluminium-free allergy vaccines and diagnostics. It uses Micro Crystalline Tyrosine (MCT) as an alter …
  • Microbix Biosystems Inc (MBX):企業の財務・戦略的SWOT分析
    Summary Microbix Biosystems Inc (Microbix) provides biological and technology solutions for human health and wellbeing. The company's products include infectious disease antigens and quality assessment products. It manufactures viral and bacterial antigens and reagents for the diagnostics. Microbix …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆